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ABSTRACTOne of the most common form of extra-pulmonary tuberculosis (TB) is peripheral tuberculous lymphadenitis and accounts for 20-40% of thecases. Tuberculous lymphadenitis has a gender and age predilection (usually seen in young females). It is usually bilateral in presentation and isnoncontagious. Recent upsurge in HIV coinfection has challenged the diagnosis and management of TB and of associated lymphadenopathy. In theendemic areas, tuberculous lymphadenitis remains an important and essential differential diagnosis in patients presenting with cervical swellings.A timely and accurate diagnosis is mandatory to overcome this public health threat. Interdisciplinary involvement of varied medical and dentalprofessionals enhances the possibility of an effective and timely diagnosis of this condition.
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INTRODUCTIONTuberculosis (TB) is a multisystemic chronic infection caused by
Mycobacterium TB and characterized by granuloma formation. Theprimary organ involved is the lungs, although disease other organs andsystems may also be affected. 25% of the cases are attributable to extra-pulmonary TB with 10-35% detected in the head and neck region [1,2].TB of the lymphatic system is the most common extra-pulmonary formof TB, second only to tuberculous pleurisy [3]. Cervical tuberculouslymphadenopathy (LD) accounts to the most frequent cause ofpersistent cervical lymphadenitis in the developing countries [4].
CLINICAL FEATURESThe  predilection for younger  age  groups  and female  gender formsthe distinguishing features for  TB lymphadenitis [5]. The conditionusually affects individuals in the age range of 20-40 years [6]. Theunderprivileged state of women in rural Indian society may be a factorfor unusual age and gender distribution [7].Tuberculous lymphadenitis manifests as a slowly enlarging painlessswelling of one or more lymph nodes of weeks to months interval.Systemic symptoms, i.e. fever, weight loss, fatigue and night sweatsmay occur in patients with extensive disease or coexisting disease. Theinitial presentation of TB lymphadenitis is firm, discrete, and mobilenodes with free overlying skin. Later, the nodes may become mattedwith inflamed overlying skin. Softening of the nodes with formationof abscesses and sinus tracts takes place in the advanced stages ofthe disease. Compression or invasion of the adjoining structures mayoccur in cases of unusually large nodes, complicating the course of thedisease [8].Jones and Campbell classification for tuberculous lymphadenitis - [9].• Stage 1 - Reactive lymphadenitis - discrete, enlarged, mobile, ϐirm,nodes with features of nonspeciϐic reactive hyperplasia• Stage 2 - Periadenitis - Rubbery lymph nodes ϐixed to adjoining tissues• Stage 3 - Formation of a cold abscess with softened central region• Stage 4 - Presence of collar-stud abscess• Stage 5 - Sinus tract formation.
Essential features of a tuberculous sinus are bluish, thin, underminededges with little clear exudates [10]. Three essential features oftuberculous lymphadenitis are multiple, matted caseating lymph nodes.Often, the LD is bilateral and noncontiguous [11].The recent upsurge in HIV coinfection has challenged the diagnosis andmanagement of TB and of associated LD.
DIAGNOSISIn patients presenting with chronic lymph node enlargement, TBshould be given the first differential diagnosis [12].Regardless of recent advances in diagnostic laboratory skills,mycobacterial cervical lymphadenitis still remains a diagnostic dilemmafor many clinicians. It is mandatory to differentiate between tuberculousand nontuberculous mycobacterium cervical lymphadenitis as themanagement strategies varies for the two entities [13].Table 1 show tuberculous lymphadenitis and nontuberculouslymphadenitis: Differentiating features [12].1. Age more than 40-50 years. TB lymphadenitis has a predilection foryounger age group (20-40 years)2. Lymphadenitis of the supraclavicular region may be indicative ofmalignancy3. No previous history of TB exposure4. A questionable repeat ϐine needle aspiration cytology (FNAC).5. Nonreactive montoux test6. Persistance of clinical symptoms and LD after starting anti-TB therapy(ATT).Most cases of nonresistant TB LD shows lymph node regressionwithin 2-4 months after initiation of ATT. Lack of resolution after2 months of starting therapy should highlight the resistant TB ornon-TB causes.Diagnostic aids for tuberculous lymphadenitis can be broadly divided into:• Primary diagnostic aids• Ancillary diagnostic aids.
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lymphadenitisAge range (years) 20-40 40-60Birth country TB endemic Non TB endemicLocation Cervical CervicofacialPulmonary disease Common AbsentTuberculin skin test Positive Occasionally positiveFNAC FNAC is A questionable repeat FNACMalignancy conclusiveNot indicative Supraclavicularlymphadenitis is indicativeof malignancyPrognosis Cessation Persistance of clinicalof clinical symptoms and LD aftersymptoms starting anti-TB therapyand LD AfterStartinganti-TB therapy
PRIMARY DIAGNOSTIC AIDSCulture or polymerase chain reaction (PCR) is essential aids for aconclusive diagnosis of tuberculous lymphadenitis [14].
CultureMycobacterial culture has been the diagnostic choice for tuberculouslymphadenitis. Culture results may be achieved by the use of variousmedia such as Lowenstein Jenson, Middlebrook, BACTEC TB. Majordrawback  with  the  use  of  culture  is  its  slow  growth.  (requires atleast 4 weeks for mycobacterial growth). Micro colony detection onsolid media, septicheck acid fast bacilli (AFB) method, microscopicobservation of broth culture, BACTEC 460 radiometric system, BACTECMGIT 960 system, MB/BacT system and ESP II culture system are someof the recent rapid methods used [15] (Fig. 1).
SmearsZiehl–Nelson (ZN) staining - ZN staining is an essential diagnostic toolfor the identification of AFB and the evaluation of treatment outcomein TB [16]. Bright red rods against blue, green or yellow backgroundare characteristic of AFB [3] (Fig. 2). Major limitations of ZN staininginclude delayed results, low sensitivity, and use of oil immersion.Auramine fluorescence - bright rods against dark background are seenwith the use of fluorescent microscope [7]. Fluorescent microscopyprovides results in a less time and using lower magnifications. Auramine-rhodamine or Papanicolaou staining using fluorescent microscope hasbeen suggested to be advanced aid to ZN staining [17,18] (Fig. 3).
FNACFNAC is almost safe, cost-effective and conclusive procedure [19].It serves as a substitute to excision biopsy for lymph nodes and isan easy  procedure for  sample  collection for cytomorphological and
bacteriological examination   [20].   FNA   cytology   has   a sensitivityand specificity of 88% and 96%, respectively, in case of tuberculouslymphadenitis diagnosis [21]. The diagnostic accuracy of mycobacterialcervical lymphadenitis may be greatly enhanced when FNAC is usedalong with culture or a mantoux test [22-24] (Fig. 4).
Excisional biopsy and histopathology The literaturehasclassicallysupportedexcisionalbiopsyasthe definitive diagnostic procedure fordiagnosis of nodal TB [25,26]. Caseating granulomas with giantcells (langhans and foreign body giant cells) are characteristic for TB.Limitations associated with histopathology are (a) invasive procedure(b) lack of facilities in peripheral health-care centers incisional biopsyis associated with sinus tract and fistula formation, and therefore, iscontraindicated [27]. Presently, this technique has been largelyreplaced by FNAC and histopathology is only reserved for patientswith negative FNA despite high clinical suspicion (Fig. 5).
PCRThe PCR has emerged as a significant aid in the diagnosis of
Mycobacterium TB   in   developed   countries   [28].   Its   sensitivityranges  between  43%  and  84%,  and  its  specificity  between  75%and 100% [29,30]. PCR is the test of choice in smear and culturenegative cases [31]. PCR outweighs the conventional diagnosticmethods because it is highly sensitive, results can be obtained in fewhours, provides distinction between Mycobacterium TB complex andmycobacterial species other than TB, and identifies drug resistancegene mutations [32,33].
Table 1: Differences between tuberculous and non tuberculous
lymphadenitis
Fig. 2: Ziehl–Nelson staining showing bright red rods against blue
background
Fig. 1: Lowenstein Jenson Culture medium showing
Mycobacterium tuberculosis growth
Fig. 3. Auramine-rhodamine staining showing bright rods against
dark background
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Fig. 4: Fine needle aspiration cytology showing cellular aspirate
with giant cells and necrotic debris
Fig. 7: Calcified radiopaque cavitary lesions
Fig. 5: Histopathology showing typical granulomatous lesion with
epitheloid cells and lymphocytes
Fig. 6: Induration on the forearm, showing positive tuberculin test
ANCILLARY DIAGNOSTIC TESTS
Tuberculin skin test/mantoux test (TST)It is an intradermal test that demonstrates a delayed typehypersensitivity reaction against mycobacterial antigen. In general, aprotein purified derivative is used as the reagent.
Fig. 8: Arrows indicating hypoechoic lymph nodes
The positive test can be detected after 2-10 weeks of mycobacterialinoculation.False positive TST reactions may occur in individuals with previousBCG vaccination or nontuberculous mycobacterial infections [31].Interferon-γ release assays have greater specificity than the TST as theydo not show false positive reactions with bacille Calmette-Guérin (BCG)or nontuberculous mycobacteria other than Mycobacterium marinum,
Mycobacterium kansasii, and Mycobacterium szulgai [34] (Fig. 6).
Chest radiographsChest radiographs may reveal multiple areas of radiolucency (darkenedareas), cavities, infiltrates or consolidation in a TB patient [7]. About10-40% of the patients show positive chest radiograph findings [13](Fig. 7).
UltrasoundUltrasound has been used as a rapid, noninvasive, economical,repeatable, and easily available aid for the assessment of cervicallymph nodes. The cytological and pathological details (by theuse of ultrasonography guided FNAC and cervical node biopsy)significantly enhances the diagnostic precision of ultrasound [35].Neck ultrasound reveals increased edema in the surroundingsoft-tissue, homogeneity, matting, intranodal cystic necrosis, andposterior enhancement, along with the appearance of lymph nodemetastases [13] (Fig. 8).
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Computed tomography (CT) and magnetic resonance imaging
(MRI)Exact location and extent of the infection may be demonstrated by CTand MRI. Initially, the nodes appear as enlarged, well-defined lymphnodes with homogenous contrast enhancement. Advanced cases showmatting with central low attenuation on CT and iso- or hypointense onT2-weighted imaging [36].
CONCLUSIONUnfortunately, despite several diagnostic aids, TB still remains as one ofthe leading cause of death from a single infectious organism. About 32%of the global population is infected with TB and an estimated 2 millionpeople die annually from this treatable disease [37]. The launch of thedirectly observed treatment short-course strategy by the World HealthOrganization was expected to substantially curb the incidence of TB [38].However, an increase in the incidence of mycobacterium TB strainresistance or reduced responsiveness to the first line of anti-TB drugs isa major contributory factor to the current spike in the incidence of thisepidemic worldwide [39]. Multidrug-resistant tuberculosis (MDR-TB)is defined as bacilli resistant to at least two first-line agents, isoniazidand rifampin. Drug-resistant tuberculosis developed due to improperprevious treatment or interruption of tuberculosis treatment. Treatmentof multidrug-resistant TB (MDR-TB) is more than 100 times as costlyas treatment of drug susceptible TB, difficult, less effective, requiringintensive care management for its prolonged (18-24 months) and moretoxic treatment course [40]. A confirmed diagnosis and differentialdiagnosis usually needs  a high level of expertise and application ofa variety of diagnostic modalities. Ideally, diagnosis and treatmentshould be based on the location of the disease and a thorough clinicalevaluation depending on the individual. Treatment with antituberculousmedication is essential. Surgery may be required in selected cases.
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